Name | Type | Posted | Actions |
|---|---|---|---|
Battelle Chem IDIQ J and A.pdf | Apr 22, 2026 |
Justification and Approval for Other than Full and Open Competition _ Nonclinical Chemical Network IDIQ Provider
Contact and place of performance
Danielle Hinton
USA
Justification and Approval to increase the ceiling on Indefinite Delivery/Indefinite Quantity (IDIQ) contract 75A50122D00007 (P00008) to Battelle Memorial Institute. The ceiling was increased by $22.5M from $45M to $67.5M, due to in-scope modifications required to the current deliverables on two (2) Task Orders and one (1) Task Order to be awarded via sole-source.
There were no changes to the scope of the work, period of performance, or terms and conditions to the contract. See attached Justification and Approval.
The Administration for Strategic Preparedness and Response has issued a Justification and Approval to increase the ceiling on Indefinite Delivery/Indefinite Quantity contract 75A50122D00007 (P00008) awarded to Battelle Memorial Institute. This action increases the total contract ceiling by $22.5 million, raising the value from $45 million to $67.5 million. The increase supports in-scope modifications for deliverables on two existing task orders and facilitates one additional task order to be awarded via sole-source. The underlying scope of work, period of performance, and terms and conditions remain unchanged.
This requirement is classified under NAICS 541714 for Research and Development in Biotechnology (except Nanobiotechnology) and PSC AN12 for Health R&D Services; Health Care Services; Applied Research. The contract pertains to the Nonclinical Chemical Network and is performed within the United States. Documentation associated with this action includes one attachment titled Battelle Chem IDIQ J and A.pdf, published on April 22, 2026. Danielle Hinton is the designated point of contact for this notice.
Generated by Lumen AI
Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.